<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/department-of-health-and-social-care">
      <span class="gem-c-organisation-logo__name">Department<br>of Health &amp;<br>Social Care</span>
</a>
</div>
        </li>
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link brand__border-color" href="/government/organisations/nhs-commissioning-board">
      <span class="gem-c-organisation-logo__name">NHS England</span>
</a>
</div>
        </li>
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Appendix D: influenza vaccines for the children’s programme
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 22 April 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan/appendix-d-influenza-vaccines-for-the-childrens-programme
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<p>The UK Health Security Agency (<abbr title="UK Health Security Agency">UKHSA</abbr>) procures and supplies the vaccines for the children’s programme. This includes the live attenuated influenza vaccine (<abbr title="live attenuated influenza vaccine">LAIV</abbr>) administered as a nasal spray which is suitable for use in children aged 2 to less than 18 years except where contraindicated.</p>

<p>Children in at-risk groups for whom <abbr title="live attenuated influenza vaccine">LAIV</abbr> is unsuitable, and healthy children whose parents object to <abbr title="live attenuated influenza vaccine">LAIV</abbr> on the grounds of its porcine gelatine content, should be offered the injectable cell-based Quadrivalent Influenza Vaccine (<abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr>) if aged 2 years to less than 18 years.</p>

<p>Children aged 6 months to less than 2 years should be offered egg-grown quadrivalent influenza vaccine (<abbr title="quadrivalent influenza vaccine, egg based">QIVe</abbr>). Centrally supplied children’s vaccines can be ordered through the <a class="govuk-link" href="https://portal.immform.phe.gov.uk/" rel="external">ImmForm website</a>.</p>

<p>The Joint Committee on Vaccination and Immunisation (<abbr title="Joint Committee on Vaccination and Immunisation">JCVI</abbr>) has advised that egg-allergic children aged less than 2 years can be offered the quadrivalent inactivated egg-free vaccine, <abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr> (Flucelvax® TETRA). This is an off-label recommendation which is supported by unpublished data which shows non inferiority of immunogenicity and a very similar safety profile for <abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr> compared with <abbr title="quadrivalent influenza vaccine, egg based">QIVe</abbr> in children less than 2 years old.</p>

<h2>Table 2. Summary table of which influenza vaccines to offer to children</h2>

<table>
  <thead>
    <tr>
      <th scope="col">Eligible   group</th>
      <th scope="col">Type of influenza vaccine</th>
      <td style="text-align: center"></td>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>At risk children aged from 6 months to less than 2 years</td>
      <td>Offer <abbr title="quadrivalent influenza vaccine, egg based">QIVe</abbr>.</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>&nbsp;</td>
      <td>For egg-allergic children under 2 years it is advised that <abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr> is   offered off-label.</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>At risk children aged 2 to under 18 years</td>
      <td>Offer <abbr title="live attenuated influenza vaccine">LAIV</abbr>.</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>&nbsp;</td>
      <td>If <abbr title="live attenuated influenza vaccine">LAIV</abbr> is contraindicated (or it   is otherwise unsuitable) offer <abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr> <sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>Aged 2   or 3 years on 31 August 2022</td>
      <td>Offer <abbr title="live attenuated influenza vaccine">LAIV</abbr>
</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
    <tr>
      <td>Primary   school aged children (aged 4 to 10 on 31 August 2022)</td>
      <td>If <abbr title="live attenuated influenza vaccine">LAIV</abbr> is contraindicated (or it   is otherwise unsuitable) offer <abbr title="quadrivalent influenza vaccine, cell based">QIVc</abbr> <sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td style="text-align: center">&nbsp;</td>
    </tr>
  </tbody>
</table>

<p>Timing of vaccine availability should be taken into account when vaccination sessions are being arranged. The latest and most accurate information on availability of centrally supplied influenza vaccines for the children’s programme will be made available on the ImmForm news page.</p>

<p>As in previous seasons, ordering controls will be in place for Fluenz® Tetra in 2022 to 2023 to enable <abbr title="UK Health Security Agency">UKHSA</abbr> to manage vaccine availability and demand appropriately across the programme. The latest information on ordering controls and other ordering advice for <abbr title="UK Health Security Agency">UKHSA</abbr> supplied influenza vaccines will be featured on the ImmForm news page both prior to and during the influenza vaccination period. Information will also be featured in <a class="govuk-link" href="http://www.gov.uk/government/collections/vaccine-update">Vaccine Update</a> and disseminated via the National Immunisation Network as appropriate. It is strongly advised that all parties involved in the provision of influenza vaccines to children ensure they remain up to date with this information at all times until the end of the 2022 to 2023 programme.</p>

<div class="footnotes" role="doc-endnotes">
  <ol>
    <li role="doc-endnote">
      <p><abbr title="quadrivalent influenza vaccine, egg based">QIVe</abbr> is suitable to offer as a second option but has not been procured by <abbr title="UK Health Security Agency">UKHSA</abbr> for this age group.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:1" role="doc-backlink">↩</a>&nbsp;<a aria-label="go to where this is referenced 2" class="govuk-link" href="#fnref:1:1" role="doc-backlink">↩<sup>2</sup></a></p>
    </li>
  </ol>
</div>
</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>